Skip To Main Content
This website is intended exclusively for healthcare professionals residing and/or working in Qatar.
Campus
Campus

Science at Sanofi

Discover a wide variety of articles, videos, podcasts, accredited courses, applications, conferences and scientific events in different therapeutic areas.

Sort by

Filters

Reset
  • Therapeutical Areas
  • Type of Content

IL-4, IL-13, AND IL-5 ARE DRIVERS OF SYSTEMIC TYPE 2 INFLAMMATION

Eosinophilic inflammation has multiple drivers1,2

Learn more

Unmet needs

Learn more

The pathophysiology of ITP stems from complex immune dysregulation drives thrombocytopenia and inflammation

Learn more

Complex immune dysregulation impact on QoL

Learn more

Interplay between the innate and adaptive immunity

Learn more

Charting New Course: The Frontier of Early Intervention and Disease Modification in AD

Learn more

Early Intervention and Disease Modification in Atopic Dermatitis

Learn more

Prevalence of Type 1 Diabetes and Daily Life Impact

Expert thoughts on the rising prevalence of Type 1 Diabetes and its implications for public health. Type 1 diabetes represents few diabetes cases globally, creating both physical and psychological challenges.

Learn more

Early Detection and Intervention

Early identification of autoantibodies can help predict T1D development before symptoms appear.

Learn more

Recommendation for Screening

Screening for individuals with first-degree relatives with T1D, particularly those with high-risk and Regular monitoring of autoantibodies and glucose tolerance can facilitate earlier diagnosis and treatment initiation.

Learn more

Stages of Type 1 Diabetes and DKA Impact

Type 1 diabetes progresses from presymptomatic autoimmunity to symptomatic hyperglycemia, ultimately requiring lifelong insulin therapy. DKA can cause severe metabolic imbalances requiring hospitalization, significantly disrupting daily life and posing serious health risks.

Learn more

TTP Patient Case Study in Kuwait

Dr. Huda Al Sahaaf discusses her experience with a 48-years-old male patient, underscoring the urgency and severe consequences of TTP when signs go unnoticed the importance of initiating aTTP treatment promptly an aTTP episode.

Learn more